myLaminin Perspectives

earn how sponsors can manage protocol deviations, amendments, eTMF documentation, and regulatory compliance in multi-site clinical trials under evolving ICH E6(R3) expectations.

Multi-site clinical trials are widely used across North America to improve recruitment and accelerate timelines, but hidden operational risks often undermine success. Site variability, uneven engagement, communication breakdowns, and fragmented technology adoption create systemic inefficiencies that erode data quality and compliance. Without integrated oversight and standardized processes, complexity scales faster than control, increasing trial failure risk.

Running clinical trials without a Clinical Trial Management System (CTMS) creates hidden operational burdens, from fragmented data and compliance risks to poor collaboration and reduced patient engagement. Disconnected tools like spreadsheets and email slow execution, increase errors, and threaten data integrity. A centralized CTMS streamlines workflows, ensures regulatory compliance, and improves trial efficiency, making it essential for scalable, secure, and successful clin

Spreadsheet-driven clinical trials introduce hidden risks in compliance, data integrity, and efficiency. While Excel remains a convenient tool, it often evolves into ungoverned infrastructure, creating version control issues, audit gaps, and costly delays. Modern CTMS platforms like myLaminin help research teams reduce spreadsheet dependency, strengthen governance, and streamline workflows without sacrificing flexibility in complex, data-intensive studies.